Latest News and Press Releases

aTyr Pharma Advances ATYR0101 to IND Candidate Stage for Pulmonary Fibrosis

Data from Phase 1 clinical trial of ATH-1105 in healthy volunteers showed a favorable safety and tolerability profile; dose proportional pharmacokinetics and CNS penetration support continued clinical...

Trial Demonstrates Superiority of Aficamten to Standard of Care Beta Blocker in Improving Peak Exercise Capacity in Patients with Obstructive Hypertrophic Cardiomyopathy SOUTH SAN FRANCISCO,...

YAVNE, Israel, May 13, 2025 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq: MDWD), a global leader in next-generation enzymatic therapeutics for tissue repair, today announced the publication of a...

Freiburg im Breisgau, Germany, May 13, 2025 – Eleva, a pioneer in discovering and developing previously inaccessible biologics based on a breakthrough technology platform, appointed Mr. Donato Spota...

BioStem Technologies Reports Preliminary First Quarter 2025 Operating and Financial Results

Siren Biotechnology to Present Universal AAV Immuno-Gene Therapy Data at the 2025 American Society of Gene and Cell Therapy (ASGCT) Annual Meeting

MaxisIT rebrands as Maxis AI, unveiling an enterprise-grade Agentic AI platform to accelerate clinical trials through intelligent, compliant automation.

Completed healthy volunteer Phase 1 clinical study of ATH-1105 as a potential treatment for amyotrophic lateral sclerosis (ALS); full healthy volunteer data expected in 2H25 On-track to enable...

Dublin, May 09, 2025 (GLOBE NEWSWIRE) -- The "Collaboration Deals in Biotechnology 2019-2025" report has been added to ResearchAndMarkets.com's offering.Collaboration Deals in Biotechnology...